Literature DB >> 22233227

Association between polypharmacy and dementia in older people: a population-based case-control study in Taiwan.

Shih-Wei Lai1, Chih-Hsueh Lin, Kuan-Fu Liao, Li-Ting Su, Fung-Chang Sung, Cheng-Chieh Lin.   

Abstract

AIM: The aim of the present study was to investigate whether polypharmacy correlates with the risk of dementia in older people.
METHODS: From representative claims data established from the National Health Insurance with a population coverage rate of 99% in Taiwan, we identified 7135 newly diagnosed patients with dementia in 2000-2008 and 2,8540 randomly selected controls without dementia, both aged ≥ 65 years. The daily use of prescribed drugs in the past 2 years was compared between cases and controls, controlling for demographic characters and comorbidities.
RESULTS: The incidence of dementia increased with the number of medications used and age. Cases were older than controls, predominant with women and more likely to use five or more drugs daily (44.0% vs 32.0%, P < 0.0001). Multivariate logistic regression analysis showed that, compared with participants using zero to one drug, the odds ratios (OR) of dementia were 1.28 (95% confidence interval [CI] 1.18-1.38) for those using two to four drugs, 1.34 (95% CI 1.23-1.46) for those using five to nine drugs and 1.56 (95% CI 1.38-1.76) for those using 10 or more drugs. Cerebrovascular disease (OR 3.19), diabetes mellitus (OR 1.23), chronic kidney disease (OR 1.21) and hypertension (OR 1.08) were significant comorbidities predicting the risk of dementia. There was significant interaction between cerebrovascular disease and the number of medications used in the dementia risk.
CONCLUSIONS: The risk of dementia increases steadily with the number of medications used and age in older people in Taiwan. Cerebrovascular disease, diabetes mellitus, chronic kidney disease and hypertension might also correlate with the risk of dementia.
© 2012 Japan Geriatrics Society.

Entities:  

Mesh:

Year:  2012        PMID: 22233227     DOI: 10.1111/j.1447-0594.2011.00800.x

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  23 in total

1.  Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hyun Soon Sohn; Jin-Won Kwon
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

2.  Geographic region and racial variations in polypharmacy in the United States.

Authors:  Winn Cashion; William McClellan; George Howard; Abhinav Goyal; David Kleinbaum; Michael Goodman; Valerie Prince; Paul Muntner; Leslie A McClure; Ann McClellan; Suzanne Judd
Journal:  Ann Epidemiol       Date:  2015-02-07       Impact factor: 3.797

3.  Psychotropic drug use and cognitive rehabilitation practice for elderly patients.

Authors:  Eiji Kose; Toshiyuki Hirai; Toshiichi Seki
Journal:  Int J Clin Pharm       Date:  2018-08-21

4.  Cataract may be a non-memory feature of Alzheimer's disease in older people.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Eur J Epidemiol       Date:  2014-04-22       Impact factor: 8.082

Review 5.  Chronotherapies for Parkinson's disease.

Authors:  Karim Fifel; Aleksandar Videnovic
Journal:  Prog Neurobiol       Date:  2019-01-15       Impact factor: 11.685

Review 6.  Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.

Authors:  Terri R Fried; John O'Leary; Virginia Towle; Mary K Goldstein; Mark Trentalange; Deanna K Martin
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

7.  Motoric Cognitive Risk Syndrome in Polypharmacy.

Authors:  Claudene J George; Joe Verghese
Journal:  J Am Geriatr Soc       Date:  2020-02-24       Impact factor: 5.562

8.  Is Polypharmacy Associated with Cognitive Frailty in the Elderly? Results from the Korean Frailty and Aging Cohort Study.

Authors:  J H Moon; J S Huh; C W Won; H J Kim
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 9.  Factors affecting the development of adverse drug reactions (Review article).

Authors:  Muaed Jamal Alomar
Journal:  Saudi Pharm J       Date:  2013-02-24       Impact factor: 4.330

10.  Statins use and female lung cancer risk in Taiwan.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Cheng-Li Lin; Fung-Chang Sung; Ya-Hsin Cheng
Journal:  Libyan J Med       Date:  2012-12-27       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.